GlassScriptPhysician profile
Brett Cagle
NPI 1790344216
$2,159.58
in general payments reported to CMS, 2019-2025
17 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $429 · 2022: $493 · 2023: $72.29 · 2024: $630 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $897.61 | 2021-2025 | Qelbree, Qelbree |
| Jazz Pharmaceuticals INC. | $206.16 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $140.00 | 2025 | Jornay Pm |
| Corium, LLC | $136.59 | 2022 | |
| Ucb, INC. | $124.97 | 2024 | Briviact |
| Takeda Pharmaceuticals U.S.A., INC. | $102.42 | 2021-2023 | Trintellix |
| Ironshore Pharmaceuticals INC. | $97.84 | 2022-2024 | |
| Sanofi Pasteur INC. | $89.33 | 2021-2022 | |
| Tris Pharma INC | $70.32 | 2021-2022 | |
| Adlon Therapeutics L.P. | $65.52 | 2021 | |
| Neos Therapeutics, LP | $63.87 | 2021-2022 | |
| Pfizer INC. | $54.82 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.81 | 2021-2022 | |
| Cipher Pharmaceuticals US LLC | $29.58 | 2025 | Spinosad, Natroba |
| Lilly USA, LLC | $15.10 | 2024 | Mounjaro |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.46 | 2024 | Ozempic, Rybelsus |
| Abbvie INC. | $13.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Cagle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.